bioRxivGeneticsPreprint
A consensus variant-to-function score to functionally prioritize variants for disease
Tabassum FabihaiD, Ivy EvergreeniD, Soumya KunduiD, Anusri PampariiD, Sergey AbramoviD, Alexandr BoytsoviD, Kari StrouseiD, Katherine DuraiD, Weixiang FangiD, Gaspard KerneriD, John Butts, Thahmina A. AliiD, Andreas R. GschwindiD, Kristy S. MualimiD, Jill E. MooreiD, Zhiping WengiD, Jacob C. UlirschiD, Hongkai JiiD, Jeff D. VierstraiD, Timothy E. ReddyiD, Stephen B. MontgomeryiD, J EngreitziD, Anshul Bharat KundajeiD, Ryan TewheyiD, Alkes L. PriceiD, Kushal K. DeyiD
- Citations
- 10
Abstract
Identifying and functionally characterizing causal disease variants in genome-wide association studies remains a pressing challenge. Here, we construct a consensus variant-to-function (cV2F) score that assigns a single value to each common single-nucleotide variant in the genome, and helps to predict and characterize causal disease variants. The cV2F score leverages features reflecting variant-level experimentally and computationally predicted function (e.g. allelic imbalance and sequence-based deep learning models) and element-level function (e.g. predicted enhancers), and learns optimal combinations of features by training a gradient boosting model on GWAS fine-mapping results. The cV2F-annotated variants attained an AUPRC of 0.822 at identifying held-out fine-mapped variants. Variants with high cV2F scores are highly enriched for heritability (14.2x, s.e. 0.5) across 66 diseases/traits, are uniquely informative for disease heritability, and are highly predictive of variants implicated by reporter assays; cV2F substantially outperforms previous variant-to-function scores using all of these metrics. GWAS fine-mapping of 110 diseases/traits informed by cV2F identified 14.3% more confidently fine-mapped (PIP > 0.95) variants than non-functionally informed fine-mapping. We further constructed tissue/cell line-specific cV2F scores that prioritize variants based on regulatory potential in specific tissues/cell lines, attaining high heritability enrichment for tissue-related diseases/traits (15.6x, s.e. 2.3) while providing independent information (average correlation of 0.27 with the primary cV2F score). We highlight examples of GWAS loci for which cV2F pinpoints causal variants with high confidence and elucidates their functional role.
- organism: human
- assay: whole-genome sequencing
- research focus: fine-mapping
- approach: statistical model
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- A machine-learning framework to characterize functional disease architectures and prioritize disease variants
Siliangyu Cheng, Artem Kim, … Steven Gazal·medRxiv·Oct 23, 2025
- Genome-wide fine-mapping improves identification of causal variants
Yang Wu, Zhili Zheng, … Jian Zeng·Nature GeneticsPeer-reviewed·Mar 30, 2026
- Borzoi-informed fine mapping improves causal variant prioritization in complex trait GWAS
Divyanshi Srivastava, Anna Korsakova, … David R. Kelley·bioRxiv·Jul 9, 2025
- Multiple instance fine-mapping: predicting causal regulatory variants with a deep sequence model
Alexander Rakowski, Christoph Lippert·PLoS GeneticsPeer-reviewed·Jun 29, 2026
- From GWAS Variant to Function: a Study of ~148,000 Variants for Blood Cell Traits.
Quan Sun, Cheynna Crowley, … Yun Li·Human Genetics and Genomics AdvancesPeer-reviewed·Oct 12, 2021
- SparsePro: an efficient fine-mapping method integrating summary statistics and functional annotations
Wenmin Zhang, Hamed Shateri Najafabadi, Yue Li·PLoS GeneticsPeer-reviewed·Dec 28, 2023